To address this issue, CP-96345, a specific NK1R antagonist was used to explore the effects of pharmacological disruption to the SP–NK1R system for acute pancreatitis and associated lung injury in mice, as in their subsequent study [89]. Here, TACR1 is linked to acute pancreatitis.